Every October the same display appears at the front of the pharmacy: vitamin D, promoted on a seasonal promise, as though the shortening days were themselves a deficiency. The vitamin is real, and so is the seasonal question behind it — sunlight is the body’s main route to it, and sunlight is what autumn takes away. Less clear is how much of the sales pitch the guidance and the trials actually support.

A nutrient the body mostly makes for itself

Vitamin D is unusual among the essentials. It is both a nutrient we eat and a hormone the body produces, and Harvard’s T.H. Chan School of Public Health notes it has long been known for helping the body absorb and retain calcium and phosphorus — the minerals bone is built from. MedlinePlus, the National Library of Medicine’s consumer encyclopedia, lists the wider roles: muscles need it to move, nerves need it to carry messages, and the immune system uses it against bacteria and viruses.

There are three routes to it — skin, diet and supplements — and the first depends on sunlight. Skin production is the primary natural source, Harvard explains, but many people run insufficient levels because they live where sunlight is limited in winter or spend most of the day indoors. People with darker skin tend to have lower blood levels, because melanin acts like a shade over that production. In the United States, Harvard reports that about 20% of White adults and 75% of Black adults have blood levels below 50 nmol/L.

Diet rarely closes the gap by itself. Very few foods contain vitamin D naturally, MedlinePlus notes: what most people eat is fortified — milk, cereal, yogurt — while egg yolks, saltwater fish and liver supply it in its natural form. NIAMS, the NIH institute for bone and musculoskeletal health, lists “a nutritious diet rich in calcium and vitamin D” among the steps that help maintain bone strength.

The amounts the guidance actually sets

The reference intake is modest. Both MedlinePlus and Harvard put the recommended dietary allowance for adults aged 19 to 70 at 600 IU (15 mcg) a day, rising to 800 IU (20 mcg) for adults over 70. The allowance assumes minimal sun exposure, which is precisely the autumn and winter case. Harvard puts the tolerable upper intake level — the most that is unlikely to cause harm — at 4,000 IU (100 mcg) a day for adults and children aged nine and over.

Some groups may need more than the baseline, MedlinePlus says: older adults, breastfed infants, people with darker skin, people whose conditions limit fat absorption (Crohn’s disease, celiac disease, ulcerative colitis), and people with obesity or a history of gastric bypass surgery. It also notes that a provider may want to test vitamin D levels before recommending a supplement.

Routine testing, though, is not a settled matter. In its current recommendation statement, the U.S. Preventive Services Task Force gives an I grade to screening for vitamin D deficiency in asymptomatic, community-dwelling, nonpregnant adults — meaning the evidence is insufficient to weigh the benefits and harms. The task force found the overall evidence on the benefits of screening to be lacking, and calls for more research.

What the trials found, and what they did not

The evidence for benefits beyond bone health remains genuinely mixed, and the largest trials are the least flattering to the supplement aisle. Harvard reports that the VITamin D and OmegA-3 TriaL (VITAL) followed 25,871 men and women aged 50 and over, giving them 2,000 IU of vitamin D or a placebo daily for a median of about five years. It did not find a protective effect on total, hip or spine fractures; it did not find that supplementation reduced falls; and it found no significantly different rates of breast, prostate or colorectal cancer between the groups.

The bone evidence is more nuanced than either the aisle or the sceptics suggest. A meta-analysis of 12 randomised trials covering more than 42,000 people aged 65 and over found that higher intakes — roughly 500 to 800 IU a day — reduced hip and non-spine fractures by about 20%, while intakes of 400 IU or less offered no benefit. A separate review of 53 trials with 91,791 participants found no strong association between vitamin D alone and fracture prevention, but a small protective effect across all fracture types when it was taken with calcium. On falls, a combined analysis found that 700 to 1,000 IU a day lowered risk by 19%, while 200 to 600 IU did not — yet VITAL, at 2,000 IU, found no reduction at all.

High doses are not the harmless option they are often assumed to be. Harvard cites a trial that gave women aged 70 and over a single yearly dose of 500,000 IU for five years: compared with placebo, it was associated with a 15% higher risk of falls and a 26% higher risk of fractures.

The immune-system aisle, read carefully

Vitamin D’s immune role is where the seasonal marketing works hardest, and where this year’s literature is most easily over-read. Laboratory work does show the vitamin helping to control infections, but human trials have been less tidy.

A network meta-analysis published in BMC Infectious Diseases pooled 19 randomised trials involving 11,576 children. In direct comparisons, low-dose vitamin D, vitamin A, vitamin A with zinc, and zinc were not significantly different from placebo for preventing respiratory infections. The network ranking leaned toward high-dose vitamin D instead (odds ratio 0.76; 95% credible interval 0.61 to 0.94), but the authors present that as a trend from an exploratory ranking, not a dosing strategy — the review had no answer to give on how much, for whom, or for how long.

A second 2026 review, in Frontiers in Immunology, looked at chronic rhinosinusitis: 12 studies and 1,236 participants. Patients with the condition had lower vitamin D levels than controls (pooled mean difference −12.09 ng/mL) and lower levels tracked with more severe disease, with deficiency rates above 90% among patients with nasal polyps. Supplementation was associated with better symptom, quality-of-life and radiological scores, and one comparison reported much lower post-surgical recurrence (24.1% versus 51.6%). The caveats matter as much as the numbers: the included studies were mostly observational rather than randomised, the samples were small, and the pooled symptom-score analysis showed no significant difference. The authors describe supplementation as a promising adjunct and ask for proper randomised trials before guidelines can say anything.

Where the pitch outruns the evidence

Three moves are common in autumn advertising and none of them follow from the sources above. The first is the promise of an immune “boost” — the vitamin supports normal immune function, which is not the same as preventing an infection. The second is the implication that everyone needs a high dose: the reference intake is 600 IU for most adults, and 4,000 IU is the level guidance treats as an upper limit rather than a target. The third is the idea that a pill replaces the eating pattern. NCCIH is explicit that multivitamin and multimineral products cannot take the place of eating a variety of foods, that most studies have shown little or no effect of such products on the risk of health problems, and that fortified food and supplements together can push total intake past the safe upper limits.

The same lesson ran through our look at the cold-and-flu “immune boost” aisle a few days ago: where popular remedies have evidence, it is narrow and specific, and where it is thin, the marketing is loudest.

What the sources support

For most healthy adults, the honest summary is undramatic. Vitamin D matters, the reference intake is small, and it assumes exactly the limited sunlight that autumn brings. If you eat fortified foods and spend time outdoors, you may already be covered. If you fall into one of the groups MedlinePlus lists, or you take a medication that interferes with vitamin D metabolism, that is a conversation for a healthcare professional — as is testing, and any dose above the everyday level. Deficiency is a clinical finding that should be treated; a supplement bought because the calendar turned is a different thing entirely.

What the guidance does support is a seasonal eating pattern rather than a seasonal pill — the same point we made in our piece on fall produce: the foods that turn up in October bring fibre, potassium and a variety of nutrients, not a single headline vitamin.

None of this is a diagnosis, a treatment plan or individual advice, and nothing here should be read as one — the position set out in our medical disclaimer.